United Microelectronics Settles Patent Lawsuit Ahead of Trial, Avoiding Potential Disruptions in Semiconductor Sector

United Microelectronics Corp. (UMC), a prominent Taiwanese semiconductor manufacturer, has announced a settlement in a patent infringement lawsuit involving seven semiconductor technologies formerly belonging to Panasonic Corp. This agreement was reached just days before the case was slated to go to trial in a Texas federal court. The settlement details have not been publicly disclosed,…

Read More

BMW Faces Patent Infringement Lawsuit Over Wireless Charging Technology in New Jersey Federal Court

BMW is facing legal challenges in New Jersey as an electronics manufacturer has filed a patent infringement lawsuit against the automobile giant. The complaint centers around a purported violation involving the wireless charging feature integrated into certain BMW models. This accusation was filed in New Jersey federal court, alleging that BMW’s technology directly infringes on…

Read More

Federal Circuit’s Ruling in Amazon vs. AlterWAN Patent Case Highlights Ongoing Challenges in Tech Industry Litigation

The Federal Circuit has opted not to revisit a panel ruling favoring Amazon in a patent litigation case involving AlterWAN Inc. The decision by the full court leaves intact a prior ruling, in which a divided panel concluded that Amazon did not infringe on AlterWAN’s network technology patent. This outcome marks a significant moment in…

Read More

USPTO Upholds Merck’s Patent Challenge in Vaccine Dispute with Pogona LLC, Dismissing Claims of Abuse

The head of the U.S. Patent and Trademark Office, Kathi Vidal, has dismissed the claim that Merck’s intellectual property challenge against Pogona LLC was an “abusive” tactic. This dispute centered on a patent related to the selection of bacteria for a vaccine against pneumococcal disease. Pogona LLC, which owns the patent, argued that Merck’s actions…

Read More

Autonomous Solutions Startup Challenges Caterpillar’s Patents Under Alice Test in Delaware Court

In a recent legal confrontation, an autonomous solutions startup has argued before a federal judge in Delaware that patents held by Caterpillar Inc. encompass rudimentary tasks associated with controlling machinery directions, challenging their validity under the U.S. Supreme Court’s Alice test. This case brings attention to ongoing debates concerning the scope and applicability of patents…

Read More

Sanofi-Aventis Settles Antitrust Case Over Insulin Pen Monopoly Allegations

Sanofi-Aventis US has reached a settlement in a significant antitrust litigation case that accused the pharmaceutical giant of attempting to stifle competition for its single-use insulin injector pens. The settlement, reached with a group of drug wholesalers, was announced to a Massachusetts federal court, avoiding a trial that could have widely influenced the legal landscape…

Read More

Bristol-Myers Squibb Urges Second Circuit to Sustain Dismissal of Antitrust Claims Over Pomalyst Patents

Bristol-Myers Squibb and its subsidiary Celgene Corporation have recently defended against an antitrust lawsuit related to the cancer drug, Pomalyst. The pharmaceutical giant urged the Second Circuit to uphold the dismissal of a class-action suit filed by health plans. The plaintiffs accused Celgene of fraudulently procuring patents to block generic competition for Pomalyst. Celgene has…

Read More

Federal Circuit Review: Key November Cases to Shape Future of Patent Law and Government Liability

As November approaches, the Federal Circuit is set to hear several pivotal cases that could have significant implications for intellectual property law and government liability. One of the key cases involves whether the U.S. government can be held accountable for patent infringement related to Moderna’s COVID-19 vaccines. This case could determine the scope of liability…

Read More

Federal Circuit’s November Docket: Key Patent Cases Poised to Redefine Legal Precedents

As the Federal Circuit prepares for its November docket, legal professionals are closely monitoring three pivotal cases that could have significant implications. First on the agenda is the high-stakes debate surrounding whether the U.S. government can be held liable for patent infringement allegations linked to Moderna’s COVID-19 vaccines. This case could redefine governmental immunity in…

Read More

CrowdStrike Challenges Venue in Patent Suit: A Strategic Legal Battle Unfolds

Cybersecurity company CrowdStrike is attempting to persuade the Federal Circuit to compel a transfer of a patent infringement suit from Texas to California. The contentious legal battle involves allegations that CrowdStrike infringed on various patents owned by the University Technology Licensing Program, a subsidiary of Arizona State University, highlighting a strategic maneuver by the company…

Read More

Smucker Defends Uncrustables Trademark Amid Fraud Allegations by Trader Joe’s in Federal Court Battle

In a legal skirmish that has drawn attention within intellectual property circles, Smucker is defending its trademark registrations for crustless peanut butter and jelly sandwiches against allegations by Trader Joe’s. The grocery chain claims that the trademarks were obtained fraudulently, leading to a request for their cancellation. However, Smucker countered in an Ohio federal court…

Read More

Samsung Challenges Whirlpool Patent in U.S. Review, Spotlighting the Role of Inter Partes Reviews in IP Law

In a recent development, U.S. Patent and Trademark Office Director John Squires addressed the decision to institute an inter partes review (IPR) of a Whirlpool dishwasher utensil caddy patent. During the review process, it was determined that part of the patent’s claims overlapped with an earlier patent application. This acknowledgment came after Samsung Electronics contested…

Read More

Apple and Microsoft Face Legal Challenge Over Patented Cybersecurity Technologies in Texas Court

Tech giants Apple Inc. and Microsoft Corp. find themselves embroiled in a legal battle as a cybersecurity firm has sued both companies in a Texas federal court. The firm accuses the technology leaders of infringing on two patents related to the detection of memory corruption, a critical component in safeguarding computer systems from potential exploits….

Read More

Pharmaceutical Giants Seek Third Circuit Appeal in Antitrust Case Over Cancer Drug Revlimid

In a significant development within the pharmaceutical industry, Bristol-Myers Squibb and several other prominent pharmaceutical companies, including Natco Pharma and AbbVie, are currently seeking an interlocutory appeal to the Third Circuit for an ongoing antitrust multidistrict litigation. This legal battle centers around Celgene Corp.’s cancer drug, Revlimid, and follows a decision by a New Jersey…

Read More

Amazon Enhances Brand Registry Amidst USPTO’s Crackdown on Trademark Fraud

Amazon has taken notable strides to bolster its Brand Registry program, a pivotal move aimed at safeguarding the intellectual property of sellers on its platform. This initiative is part of Amazon’s broader strategy to enhance consumer trust and brand reputation by fighting counterfeit products. The Brand Registry program provides sellers with advanced tools to manage…

Read More

Sterlington PLLC Strengthens Patent Law Expertise with Key Additions from Holland & Hart

Sterlington PLLC has strategically expanded its intellectual property capabilities by bringing aboard a nine-member patent team from Holland & Hart LLP. This move, disclosed earlier this week, is spearheaded by two leading partners, marking a significant shift in the competitive landscape of patent law. The newly assembled team at Sterlington is expected to enhance the…

Read More

Fortinet Faces Patent Infringement Suit from Long Horizon Technologies in Texas Courtroom Showdown

In a patent lawsuit filed in the Eastern District of Texas, Long Horizon Technologies LLC has brought allegations against Fortinet Inc., a prominent company in the cybersecurity space. The legal action centers around accusations that Fortinet has infringed on Long Horizon’s patent concerning the installation of embedded firmware, a technology critical to cybersecurity operations. This…

Read More

Vanda and Alembic Settle Patent Dispute on Generic Fanapt: Implications for Drug Accessibility and Market Competition

In a development that underlines the complexities of pharmaceutical patent disputes, Vanda Pharmaceuticals and Alembic Pharmaceuticals informed a Delaware federal court that they have reached a settlement regarding Alembic’s intended generic production of Fanapt, Vanda’s medication for schizophrenia. This resolution concludes the litigation ongoing since Alembic sought to introduce a more affordable version of the…

Read More

U.S. Startups Seek Supreme Court Review in $2.6 Billion Patent Case Against Cisco

The Alliance of U.S. Startups and Inventors for Jobs is petitioning the U.S. Supreme Court to review a significant intellectual property case involving Centripetal Networks LLC. The group contends that a $2.6 billion infringement victory against Cisco Systems was unjustly overturned without due process. They argue that the ruling threatens to disincentivize innovation among smaller…

Read More

Heartflow Inc. Sues Competitor Over Patent Infringement and Employee Poaching in AI Cardiac Imaging Industry Dispute

Artificial intelligence-driven cardiac imaging company, Heartflow Inc., has initiated a legal battle, claiming that a competitor has infringed its patents related to a noninvasive heart test. The lawsuit also accuses the rival of poaching nearly a dozen employees to develop a similar product. This legal action is a significant move as it underscores the competitive…

Read More

Ouraring Inc. Revives Legal Battle Against Ultrahuman Healthcare Over New Patent Disputes

In a renewed courtroom clash, smart ring manufacturer Ouraring Inc. has once again taken legal action against competitor Ultrahuman Healthcare Inc., asserting new claims over patent infringements. This legal move follows a previous lawsuit where Ultrahuman faced an import ban, later lifted after the company successfully redesigned its product. Ouraring’s latest complaint targets two patents…

Read More